COVID-19 pandemic in Jammu and Kashmir

• Anyone entering the UT by road, rail and air has to take mandatory COVID-19 test and undergo institutional quarantine till the test results are received.[3]
• After receiving the test results, individuals tested negative can return home but have to undertake a 14-day home quarantine. COVID positive individuals are relocated to dedicated healthcare facilities for treatment.[3]
• Travellers can also opt for a paid hospitality quarantine by registering themselves for one at KIOSKS where the samples for tests are collected.
• Travellers from Districts designated as Red zones to Orange zone Districts within the UT to undergo same testing and quarantine regime.[4]

• Pregnant women, mothers with infants below 1yr
• Cancer, chronically ill and dialysis patients
• Children below 10 yrs travelling alone
• GoI personnel on duty
• Travellers with COVID negative test certificate issued by ICMR approved lab and not older than 48hrs
• CAPF and Armed forces personnel reporting for active duty in the Union Territory, will be sent to their respective formations

• 1075 -Toll free national COVID helpline
• 0191-2549676 -UT level cell
• 0191-2520982, 0191–2674444, 0191-2674115 - Jammu Division
• 0194-2440283, 0194-2430581 - Kashmir Division

On 7 March, primary schools in Jammu and Samba districts were closed down until 31 March after two suspected cases with "high viral load" were reported in Jammu.[5]

On 15 March, Shri Mata Vaishnov Devi Shrine Board asked non-resident Indians and foreigners not to visit the temple for 28 days after landing in India.

On 18 March, Jammu and Kashmir banned entry of all foreign tourists.[6] On the other hand, the Directorate of Floriculture, Parks and Horticulture of the state extended the Bagh-e-Bahu Garden to the general public from 18 to 31 March to keep the situation under control in the Union Territory.[7][8]

The UT administration announced a slew of relaxation in accordance to the MoHFW and MHA guidelines during Lockdown 3.0 followed by more relaxations in Lockdown 4.0. Testing numbers of the J&K are highest in India at 10,000 tests per million population.[9]

The UT administration extended the Lockdown 4 restrictions till 8 June after which the Unlock-1 relaxations would be implemented as per MHA guidelines.

On 5 June, the Government ordered its employees to attend offices on regular basis beginning 6 June. High-risk groups have been advised to take extra precautions or work from home and will not be attending frontline duties or involvement in public dealings.[10]

• All districts of Kashmir Division except Ganderbal and Bandipore.
• Ramban of Jammu Division.

• Kathua district Except Lakhanpur containment zone which will be considered RED zone with 500m buffer.
• Samba
• Bandipore
• Jammu district
• Reasi
• Udhampur
• Ganderbal
• Poonch
• Rajouri

• Doda
• Kishtwar

• As of 3 June 2020, all 20 districts in the Union Territory have reported confirmed positive cases. Anantnag has reported the highest number of cases in the UT whereas, Kishtwar's count is the least till date.
• As on 12 June, total number of cases in Jammu and Kashmir was

• On 11 July, total cases in Jammu and Kashmir crossed tally of 10000.[13]
• As on 5 July, total number of cases in Jammu and Kashmir was 8429, with 3042 active cases, 5255 recoveries and 132 deaths.[14]
• As on 12 July, total number of cases was 10513, with 4355 active cases, 5979 cures and 179 fatalities.[14]
• As on 16 July, total number of cases in the UT was 12156, with 5488 active cases, 6446 recoveries and 222 fatalities.[14]
• As on 21 July, total number of cases is 15258, with 6540 active cases, 8455 cures and 263 deaths.[14]

• As of 1 August, the total number of cases in Jammu and Kashmir was 20972, including 7713 active cases, 12871 cures and 388 deaths.[15]
• As of 4 August, the total number of cases in Jammu and Kashmir was 22396, including 7123 active cases, 14856 cures and 417 deaths.[15]
• As of 9 August, the total number of cases was 24390, including 7264 active cases, 16667 cures and 459 deaths.[15]
• As of 11 August, the total number of cases was 25931, including 7462 active cases, 17979 cures and 490 deaths.[15]
• As of 14 August, the total number of cases was 27489, including 7027 active cases, 19942 recoveries and 520 deaths.[15]
• As of 19 August, the total number of cases was 30034, including 6965 active cases, 22497 cures and 572 fatalities.[15]
• As of 23 August, the total number of cases in the UT was 33705, including 7246 active cases, 25205 recoveries and 624 deaths.[15]

• As of 1 September, the total number of cases in Jammu and Kashmir was 38223, including 8022 active cases, 29484 cures and 717 deaths.[15]
• As of 6 September, the total number of cases in the UT was 43557, including 10646 active cases, 32327 recoveries and 784 deaths.[15]
• As of 16 September, the total number of cases was 58244, including 19503 active cases, 37809 recoveries and 932 deaths.[15]
• As of 21 September, the total number of cases was 65026, including 21887 active cases, 42115 cures and 1024 deaths.[15]
• As of 28 September, the total number of cases was 73014, including 17601 active cases, 54267 recoveries and 1146 deaths.[15]

• As of 2 October, the total number of cases in Jammu and Kashmir was 77253, including 16089 active cases, 59952 cures and 1212 deaths.[15]
• As of 3 October, the total number of cases was 78228, including 15646 active cases, 61351 cures and 1231 deaths.[15]
• As of 6 October, the total number of cases was 80476, including 13712 active cases, 65496 recoveries and 1268 deaths.[15]
• As of 14 October, the total number of cases was 85409, including 9739 active cases, 74318 cures and 1352 fatalities.[15]
• As of 21 October, the total number of cases was 89582, including 8088 active cases, 80092 cures and 1402 deaths.[15]
• As of 29 October, the total number of cases was 93764, including 6928 active cases, 85370 recoveries and 1466 deaths.[15]

• As of 4 November, the total number of cases in Jammu and Kashmir was 96700, including 5935 active cases, 89254 cures and 1511 deaths.[15]
• As of 10 November, the total number of cases was 99844, including 5415 active cases, 92880 cures and 1549 deaths.[15]
• As of 23 November, the total number of cases was 106899, including 5431 active cases, 99827 recoveries and 1641 deaths.[15]

• As of 2 December, the total number of cases in Jammu and Kashmir was 111130, including 4951 active cases, 104471 cures and 1708 deaths.[15]
• As of 6 December, the total number of cases was 113288, including 5170 active cases, 106372 cures and 1746 deaths.[15]
• As of 13 December, the total number of cases was 116008, including 4702 active cases, 109507 cures and 1799 fatalities.[15]
• As of 17 December, the total number of cases was 117317, including 4327 active cases, 111164 cures and 1826 deaths.[15]
• As of 28 December, the total number of cases was 120293, including 3157 active cases, 115261 recoveries and 1875 deaths.[15]
• As of 31 December, the total number of cases in the UT was 120971, including 3009 active cases, 116079 recoveries and 1883 fatalities.[15]

• As of 3 January, the total number of cases in Jammu and Kashmir was 121653, including 2975 active cases, 116792 cures and 1886 deaths.[15]
• As of 6 January, the total number of cases was 122049, including 2459 active cases, 117690 cures and 1900 deaths.[15]
• As of 10 January, the total number of cases was 122538, including 2011 active cases, 118617 cures and 1910 deaths.[15]
• As of 21 January, the total number of cases was 123764, including 1111 active cases, 120729 cures and 1924 fatalities.[15]
• As of 27 January, the total number of cases in the UT was 124234, including 1050 active cases, 121253 recoveries and 1931 deaths.[15]

• As of 1 February, the total number of cases in Jammu and Kashmir was 124550, including 709 active cases, 121905 cures and 1936 deaths.[15]

On January 1 2021, the Drug Controller General of India, approved the emergency or conditional use of AstraZeneca’s COVID-19 vaccine AZD1222 (marketed as Covishield).[16] Covishield is developed by the University of Oxford and its spin-out company, Vaccitech.[17] It's a viral vector vaccine based on replication-deficient Adenovirus that causes cold in Chimpanzees. It can be stored, transported and handled at normal refrigerated conditions (two-eight degrees Celsius/ 36-46 degrees Fahrenheit). It has a shelf-life of at least six months.

On 12 January, 2021 first batches of Covishield vaccine was despatched from the Serum Institute of India.[18]

On January 2, 2021, BBV152 (marketed as Covaxin), first indigenous vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology received approval from the Drug Controller General of India for its emergency or conditional usage.[19]

On 14 January, 2021 first batches of Covaxin vaccine was despatched from the Bharat Biotech, albeit it was still in the third phase of testing.[20]